Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Lawrenson JG, Dhakal R. Cochrane corner: Atropine: an ancient remedy for a twenty-first century problem? Eye. 2020. https://doi.org/10.1038/s41433-020-0942-9.
Chamberlain P, Peixoto-de-Matos SC, Logan NS, Ngo C, Jones D, Young G. A 3-year randomized clinical trial of misight lenses for myopia control. Optom Vis Sci. 2019;96:556–67.
Wong YL, Sabanayagam C, Ding Y, Wong CW, Yeo AC, Cheung YB, et al. Prevalence, risk factors, and impact of myopic macular degeneration on visual impairment and functioning among adults in Singapore. Investig Ophthalmol Vis Sci. 2018;59:4603–13.
Chia A, Chua WH, Cheung YB, Wong WL, Lingham A, Fong A, et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (atropine for the treatment of myopia 2). Ophthalmology. 2012;119:347–54.
Yam JC, Jiang Y, Tang SM, Law AKP, Chan JJ, Wong E, et al. Low-Concentration Atropine for Myopia Progression (Lamp) Study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control. Ophthalmology. 2019;126:113–24.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
MAB is a consultant for Alcon Laboratories, Inc. (Fort Worth, TX, USA); Apellis Pharmaceuticals, Inc. (Waltham, MA, USA); Arctic Vision, Ltd. (Shanghai, China); CooperVision, Inc. (Victor, NY, USA); Essilor (Paris, France); Eyenovia, Inc. (New York, NY, USA); Genentech, Inc. (San Francisco, CA, USA); Johnson & Johnson Vision (Jacksonville, FL, USA); Novartis Pharma AG (Basel, Switzerland); and PresbiBio, LLC (Irvine, CA, USA). NAB is an Employee of Johnson & Johnson Vision (Jacksonville, FL, USA).
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bullimore, M.A., Brennan, N.A. Comment on: ‘Cochrane corner: Atropine: an ancient remedy for a twenty-first century problem?’. Eye 35, 2638–2639 (2021). https://doi.org/10.1038/s41433-020-01165-7
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41433-020-01165-7
